SEC Form 4 · accession 0001209191-15-056195
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Asbury
Officer — See Remarks
Period of report
Jun 18, 2015
Accepted (ET)
Jun 25, 2015 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionsF1 | — | Jun 18, 2015 | A | 16,875 | A | — | — | Common Stock | 16,875 | 16,875 | D |
| Restricted Stock UnitF2 | — | Jun 18, 2015 | A | 3,000 | A | — | — | Common Stock | 3,000 | 3,000 | D |
Explanation of responses
- F1Mr. Asbury was granted an option to purchase 16,875 shares of common stock at an exercise price per share of $55.57 on June 18, 2015, of which 25% of the shares subject to such option will vest on the first anniversary of the date of grant, with the remaining 75% of the shares vesting monthly in substantially equal installments over the following 36 months, subject to Mr. Asbury's continuing to provide services to the company and to the terms of the option agreement accompanying the grant.
- F2On June 18, 2015, Mr. Asbury was granted 3,000 restricted stock units representing the right to receive one share of common stock upon vesting of each restricted stock unit. The restricted stock units vest over four years, with 25% vesting on each of the first four anniversaries of the date of grant, subject to Mr. Asbury's continuing to provide services to the company on each vesting date.
Remarks
Chief Legal Officer and General Counsel